Meeting
2020 Genitourinary Cancers Symposium
WATChmAN: A randomized trial of virtual surveillance versus standard in-person care for clinical stage I testicular cancer.
Authors
Robert James Hamilton
Division of Urologic Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
Robert James Hamilton , Lauren Landoni , Kopika Kuhathaas , Peter W. M. Chung , Philippe L. Bedard , Padraig Richard Warde , Aaron Richard Hansen , Tran Truong , Ezra Hahn , Michael A.S. Jewett
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Clinical Trial Registration Number
NCT03360994
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 396)
Abstract #
396
Poster Bd #
D17
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Stage I testicular cancer: Five-year follow-up rates and reasons for non-adherence.
First Author: Tim Karmas
Poster
2011 ASCO Annual Meeting
Evaluation of low-dose CT scans for surveillance in stage I testicular cancer.
First Author: P. W. M. Chung
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of DAZL expression with risk of recurrence in clinical stage 1 testicular germ cell tumors.
First Author: Alok Tewari
Poster
2023 ASCO Genitourinary Cancers Symposium
A multicenter prospective validation study of the 3-cm cut-off in stage I seminoma (S3MI-PT).
First Author: Mario Fontes-Sousa